Sponsored Ad | NIKKEI FORUM MELBOURNE 2025 - Leaderboard

ORI Capital exits Kymab in $1.1b deal with Sanofi, hits first close of $400m second fund

ORI Capital exits Kymab in $1.1b deal with Sanofi, hits first close of $400m second fund

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter